NXN-188

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameNXN-188
Drug Alias NameNXN-188
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric-oxide synthase, endothelial inhibitorsSerotonin 1b (5-HT1b) receptor agonistsSerotonin 1d (5-HT1d) receptor agonists
TargetsSerotonin 1b (5-HT1b) receptorNitric-oxide synthase, endothelialSerotonin 1d (5-HT1d) receptor
Therapy Area/IndicationsMigraine without AuraMigraine with Aura
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNeuraxon Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeuraxon Inc
Active IndicationsN/A
Inactive IndicationsMigraine without AuraMigraine with Aura

Other Information

ATC CodeN/A
Related LinksN/A